Streetbeat News

Analyst Ratings

NTRS

Over the past 3 months, 9 analysts have published their opinion on Northern Trust (NASDAQ:NTRS) stock. The average 12-month price target for Northern Trust is $87.28, representing a 4.61% decrease from the previous average price target of $91.50.

Portfolio Pulse from Benzinga Insights

July 05, 2023 | 1:00 pm

ECL

Analysts have provided mixed ratings for Ecolab (NYSE:ECL) in the last quarter, with 4 somewhat bullish, 4 indifferent, and 1 somewhat bearish. The average 12-month price target for Ecolab has increased by 10.47% from the previous average price target of $169.17 to $186.89.

Portfolio Pulse from Benzinga Insights

July 05, 2023 | 1:00 pm

CARG

Piper Sandler analyst Alexander Potter maintains an Underweight rating on CarGurus (NASDAQ:CARG) and raises the price target from $12 to $15.

Portfolio Pulse from Benzinga Newsdesk

July 05, 2023 | 12:59 pm

ACVA

Piper Sandler analyst Alexander Potter has maintained a Neutral rating on ACV Auctions (NASDAQ:ACVA) and raised the price target from $14 to $15.

Portfolio Pulse from Benzinga Newsdesk

July 05, 2023 | 12:55 pm

RIG

Transocean Ltd (RIG) shares are trading higher following an upgrade from Citigroup analyst Scott Gruber, who raised the price target from $6.50 to $9.50. The company also announced that $172 million in options have been exercised and it received a $184 million award for harsh environment semisubmersible.

Portfolio Pulse from Adam Eckert

July 05, 2023 | 12:55 pm

DD

RBC Capital analyst Arun Viswanathan has reiterated an 'Outperform' rating on DuPont de Nemours (NYSE:DD), maintaining a price target of $81.

Portfolio Pulse from Benzinga Newsdesk

July 05, 2023 | 12:54 pm

BLPH

CBUS

LUCY

PBLA

VOR

The article lists the top 5 oversold health care stocks with an RSI near or below 30, which could lead to significant gains in July. The companies mentioned are Cibus, Inc. (CBUS), Panbela Therapeutics, Inc. (PBLA), Vor Biopharma Inc. (VOR), Innovative Eyewear, Inc. (LUCY), and Bellerophon Therapeutics, Inc. (BLPH). All these stocks have seen a recent dip in their prices.

Portfolio Pulse from Lisa Levin

July 05, 2023 | 12:51 pm

PEB

Barclays analyst Anthony Powell maintains an Equal-Weight rating on Pebblebrook Hotel (NYSE:PEB) and lowers the price target from $135 to $125.

Portfolio Pulse from Benzinga Newsdesk

July 05, 2023 | 12:47 pm

STZ

Barclays analyst Lauren Lieberman maintains an Overweight rating on Constellation Brands (NYSE:STZ) but lowers the price target from $277 to $275.

Portfolio Pulse from Benzinga Newsdesk

July 05, 2023 | 12:43 pm

LECI

Levi Strauss & Co. (NYSE:LECI) is expected to report a sharp drop in its Q2 earnings, with analysts predicting earnings of 3 cents per share, down from 23 cents per share a year ago. The company's revenue is expected to be around $1.34 billion. Several analysts have recently adjusted their price targets for the company, with the most accurate analysts predicting an upside of 11% to 32% in the company's stock.

Portfolio Pulse from Lisa Levin

July 05, 2023 | 12:35 pm